BioSpace
APRIL 2, 2021
A current Phase III trial of the Pfizer-BioNTech COVID-19 vaccine has confirmed the protection remains high for at least six months after the second dose. In a statement, Pfizer and BioNTech reported the vaccine was 91.3% effective against the disease.
Scienmag
APRIL 2, 2021
Credit: Joshua Edson A new Veterans Affairs study finds that combat experience is associated with a higher risk of alcohol use to cope with PTSD symptoms. But the connection is weaker when accounting for the severity of the PTSD. The findings appeared online in the Journal of Dual Diagnosis in March 2021. In an observational […].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioSpace
APRIL 2, 2021
If you’re one of the 17% of Americans that have been fully vaccinated against SARS-CoV-2, you are probably feeling some level of relief. But the CDC warns not to throw your mask away just yet.
Pharma Marketing Network
APRIL 2, 2021
The AI in Healthcare Virtual Summit focused on AI methods and tools that are set to transform healthcare, medicine, and diagnostics along with the latest applications within the industry. . Here are some key sessions during the summit that discussed machine learning for antibiotic discovery, creating personalized neuro medicine using AI and brain modelling, and deep learning for biomedical imaging.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
APRIL 2, 2021
Sepsis is among the best-known and least effectively treated conditions in the modern world. The standard of care has failed for these infections, leaving the U.S. healthcare system with $62 billion and 270,000 deaths annually. Globally, 11 million die from sepsis each year. Effective drugs and d.
Scienmag
APRIL 2, 2021
Electron holes could be the solution to operational speed/coherence trade-off Credit: FLEET A new study indicates holes the solution to operational speed/coherence trade-off, potential scaling up of qubits to a mini-quantum computer. Quantum computers are predicted to be much more powerful and functional than today’s ‘classical’ computers.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
APRIL 2, 2021
It allows to kill bacteria and to raise healthy chickens with less dose of antibiotics Credit: UrFU / Ilya Safarov. Russian researchers have developed an inexpensive, safe, and reliable packed eggs surface disinfection technology. This technology helps to kill bacteria, including salmonella, on eggshells. Also, it allows growing broiler chickens with strong immunity to viral […].
BioSpace
APRIL 2, 2021
It’s something of the holy grail—run whole genome sequencing on a sample of a person’s blood and identify their risk for disease, all quickly and affordably. Oxford, England’s Genomics, founded in 2014 out of Oxford University by Sir Peter Donnelly, may be getting close.
Scienmag
APRIL 2, 2021
Credit: ©Science China Press The interfacial decomposition products forming the so-called solid-electrolyte interphase (SEI) during the first charging/discharging significantly determine the electrochemical performances of lithium (Li) batteries. To date, the dynamic evolutions, chemical compositions, stabilities and the influencing factors of the SEI films have been captured tremendous attentions.
BioSpace
APRIL 2, 2021
Gaithersburg, Md.-based Emergent BioSolutions offered an update on its Phase III trial of SARS-CoV-2 Immune Globulin Intravenous (Human) (COVID-HIG) to treat hospitalized patients with COVID-19.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
APRIL 2, 2021
Credit: Getty images DEPRIVATION among society at large is ‘driving’ Covid-19 disparities among minority ethnic groups – predominantly South Asian and Black African or Caribbean populations – and could be considered the main cause of disproportionate infection rates, hospitalisation and deaths experienced by these populations, according to new analysis from the University of Leicester.
XTalks
APRIL 2, 2021
Pfizer released new COVID-19 vaccine trial results this week from its ongoing clinical studies, which include data showing that its COVID-19 mRNA vaccine is 100 percent effective in children between the ages of 12 and 15 and has a 91 percent efficacy against variants with protection lasting at least six months. The highly awaited COVID-19 vaccine trial results address what have been three highly contested areas of concern: is the COVID-19 vaccine safe for kids, is it effective against some of th
Scienmag
APRIL 2, 2021
National Trends in Disability Employment (nTIDE) — issued semi-monthly by Kessler Foundation and the University of New Hampshire Credit: Kessler Foundation East Hanover, NJ – April 2, 2021 – The job numbers flattened for people with and without disabilities, reflecting a pause in the economic recovery from the impact of the COVID-19 pandemic, according to […].
Drug Patent Watch
APRIL 2, 2021
Annual Drug Patent Expirations for PHOSLO Phoslo is a drug marketed by Fresenius Medcl and is included in two NDAs. It is available from three suppliers. There are two patents…. The post New patent expiration for Fresenius Medcl drug PHOSLO appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
APRIL 2, 2021
Skeletal muscle satellite cells found to grow better with less glucose in vitro Credit: Tokyo Metropolitan University Tokyo, Japan – Researchers from Tokyo Metropolitan University have shown that skeletal muscle satellite cells, key players in muscle repair, proliferate better in low glucose environments. This is contrary to conventional wisdom that says mammalian cells fare better […].
Drug Patent Watch
APRIL 2, 2021
Annual Drug Patent Expirations for PHOSLO+GELCAPS Phoslo Gelcaps is a drug marketed by Fresenius Medcl and is included in one NDA. It is available from three suppliers. There are two…. The post New patent expiration for Fresenius Medcl drug PHOSLO GELCAPS appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
APRIL 2, 2021
Promising candidates include widely used transplant-rejection drug cyclosporine PHILADELPHIA – A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases.
Drug Patent Watch
APRIL 2, 2021
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are five patents…. The post New patent for Taiho Oncology drug LONSURF appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
APRIL 2, 2021
Scientists from Japan employ a novel two-step method of labeling neurotransmitter receptor proteins to track their localization efficiently Credit: Shigeki Kiyonaka The neurons in our nervous system “talk” to each other by sending and receiving chemical messages called neurotransmitters. This communication is facilitated by cell membrane proteins called receptors, which pick up neurotransmitters and relay […].
Drug Patent Watch
APRIL 2, 2021
Annual Drug Patent Expirations for NERLYNX Nerlynx is a drug marketed by Puma Biotech and is included in one NDA. It is available from one supplier. There are eight patents…. The post New patent for Puma Biotech drug NERLYNX appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
APRIL 2, 2021
Credit: Satoru Konnai Scientists in Japan have developed and tested a novel probiotic formulation to control severe diarrhea in calves, ensuring their health and reducing mortality, and in turn reducing economic loss. The health of calves is a crucial component in animal husbandry; diseases that affect calves cause economic losses to livestock farms either directly, […].
Drug Patent Watch
APRIL 2, 2021
Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are five…. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
APRIL 2, 2021
Credit: © IRD – Rafaël Almar With Global Africa, the UGB’s LASPAD (Laboratoire d’analyse des sociétés et pouvoirs / Afrique – Diasporas) aims to report on political, social, economic, environmental, and technological issues, both in Africa and around the world. The first call for papers for this multilingual journal (French, English, Arabic, and Swahili) will […].
Drug Patent Watch
APRIL 2, 2021
Annual Drug Patent Expirations for GOPRELTO Goprelto is a drug marketed by Genus Lifesciences and is included in one NDA. It is available from one supplier. There are seven patents…. The post New patent for Genus Lifesciences drug GOPRELTO appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
APRIL 2, 2021
Phenotypes I, II and III show distinct characteristics and show adverse, normal and favorable clinical outcomes respectively Credit: Lusczek et al, 2021, PLOS ONE (CC-BY 4.0, [link] In a new study, researchers identify three clinical COVID-19 phenotypes, reflecting patient populations with different comorbidities, complications and clinical outcomes.
Drug Patent Watch
APRIL 2, 2021
Annual Drug Patent Expirations for LORBRENA Lorbrena is a drug marketed by Pfizer and is included in one NDA. It is available from one supplier. There are two patents protecting…. The post New patent for Pfizer drug LORBRENA appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
APRIL 2, 2021
By blocking human enzyme cathepsin L, chemical inhibitor K777 reduces coronavirus’ ability to infect cell lines; clinical trials are underway Credit: National Institute of Allergy and Infectious Diseases, NIH James McKerrow, MD, PhD, dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, has long studied neglected tropical diseases […].
Drug Patent Watch
APRIL 2, 2021
Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. There are five patents protecting this drug. NEXLETOL drug…. The post New patent for Esperion Theraps drug NEXLETOL appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
APRIL 2, 2021
How much life is left in Texas roadways? A UTA project aims to find out. Credit: UT Arlington A University of Texas at Arlington civil engineering professor is leading a $2.8 million Texas Department of Transportation (TxDOT) project that will scan pavements on Texas roads to determine their condition and remaining service life. Ali Abolmaali, […].
Drug Patent Watch
APRIL 2, 2021
Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. There are five patents protecting this drug. NEXLIZET drug…. The post New patent for Esperion Theraps drug NEXLIZET appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
111 
Let's personalize your content